Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Two-fraction HDR Monotherapy for Localized Prostate Cancer — Stella

Home/Prostate Adenocarcinoma/Two-fraction HDR Monotherapy for Localized Prostate Cancer

View on ClinicalTrials.gov

Recruiting

Back to Prostate Adenocarcinoma trials

Two-fraction HDR Monotherapy for Localized Prostate Cancer

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

University of California, San Francisco, San Francisco, California

Key details

Sponsor

University of California, San Francisco

Enrollment target

~17 participants

Started

September 2024

Primary completion

February 2029

Age range

18 Years and older

Sex

Male only

Last updated April 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.